Cargando…

Reducing the pain: A cost-effectiveness analysis of transversus abdominis plane block using liposomal bupivacaine for outpatient laparoscopic ventral hernia repair

BACKGROUND: Transversus abdominis plane block with liposomal bupivacaine has been studied as an effective method of reducing the need for postoperative opioids and increasing same-day discharge rates. However, less is known about the cost-effectiveness of this strategy relative to opioids alone for...

Descripción completa

Detalles Bibliográficos
Autores principales: Colonna, Alexander L., Bellows, Brandon K., Enniss, Toby M., Young, Jason B., McCrum, Marta, Nunez, Jade M., Nirula, Raminder, Nelson, Richard E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097728/
https://www.ncbi.nlm.nih.gov/pubmed/33997752
http://dx.doi.org/10.1016/j.sopen.2019.12.003
_version_ 1783688371934068736
author Colonna, Alexander L.
Bellows, Brandon K.
Enniss, Toby M.
Young, Jason B.
McCrum, Marta
Nunez, Jade M.
Nirula, Raminder
Nelson, Richard E.
author_facet Colonna, Alexander L.
Bellows, Brandon K.
Enniss, Toby M.
Young, Jason B.
McCrum, Marta
Nunez, Jade M.
Nirula, Raminder
Nelson, Richard E.
author_sort Colonna, Alexander L.
collection PubMed
description BACKGROUND: Transversus abdominis plane block with liposomal bupivacaine has been studied as an effective method of reducing the need for postoperative opioids and increasing same-day discharge rates. However, less is known about the cost-effectiveness of this strategy relative to opioids alone for hernia repair. We performed an economic evaluation of these strategies using a computer simulation model. METHODS: A decision tree was constructed to determine cost-effectiveness as measured by incremental cost-effectiveness ratios per quality-adjusted life-year. Base-case costs, quality-adjusted life-year values, and probabilities were derived from published studies and Medicare fee schedules. For input parameters for which we could not find values in the published literature, we used expert opinion. A 1-month time horizon was selected to focus on the immediate postoperative period. Finally, we performed 1-way, 2-way, and probabilistic sensitivity analyses. RESULTS: The liposomal bupivacaine transversus abdominis plane block was a dominant strategy yielding a $456.75 decrease in cost and an 0.1 increase in quality-adjusted life-years relative to opioids alone. In 1-way sensitivity analysis of cost incremental cost-effectiveness ratio, values were most sensitive to variations in the amount saved by same-day discharge and the cost of bupivacaine. In probabilistic sensitivity analyses, transversus abdominis plane strategy was cost-effective at a willingness-to-pay threshold of $50,000/quality-adjusted life-year in 94.5% of iterations and at a willingness-to-pay threshold of $100,000/quality-adjusted life-year in 97.1% of iterations. CONCLUSION: The use of liposomal bupivacaine transversus abdominis plane block resulted in cost savings and improved quality-adjusted life-years in base-case analyses and was cost-effective at conventional willingness-to-pay thresholds in the majority of iterations in probabilistic sensitivity analyses.
format Online
Article
Text
id pubmed-8097728
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-80977282021-05-13 Reducing the pain: A cost-effectiveness analysis of transversus abdominis plane block using liposomal bupivacaine for outpatient laparoscopic ventral hernia repair Colonna, Alexander L. Bellows, Brandon K. Enniss, Toby M. Young, Jason B. McCrum, Marta Nunez, Jade M. Nirula, Raminder Nelson, Richard E. Surg Open Sci Article BACKGROUND: Transversus abdominis plane block with liposomal bupivacaine has been studied as an effective method of reducing the need for postoperative opioids and increasing same-day discharge rates. However, less is known about the cost-effectiveness of this strategy relative to opioids alone for hernia repair. We performed an economic evaluation of these strategies using a computer simulation model. METHODS: A decision tree was constructed to determine cost-effectiveness as measured by incremental cost-effectiveness ratios per quality-adjusted life-year. Base-case costs, quality-adjusted life-year values, and probabilities were derived from published studies and Medicare fee schedules. For input parameters for which we could not find values in the published literature, we used expert opinion. A 1-month time horizon was selected to focus on the immediate postoperative period. Finally, we performed 1-way, 2-way, and probabilistic sensitivity analyses. RESULTS: The liposomal bupivacaine transversus abdominis plane block was a dominant strategy yielding a $456.75 decrease in cost and an 0.1 increase in quality-adjusted life-years relative to opioids alone. In 1-way sensitivity analysis of cost incremental cost-effectiveness ratio, values were most sensitive to variations in the amount saved by same-day discharge and the cost of bupivacaine. In probabilistic sensitivity analyses, transversus abdominis plane strategy was cost-effective at a willingness-to-pay threshold of $50,000/quality-adjusted life-year in 94.5% of iterations and at a willingness-to-pay threshold of $100,000/quality-adjusted life-year in 97.1% of iterations. CONCLUSION: The use of liposomal bupivacaine transversus abdominis plane block resulted in cost savings and improved quality-adjusted life-years in base-case analyses and was cost-effective at conventional willingness-to-pay thresholds in the majority of iterations in probabilistic sensitivity analyses. Elsevier 2020-01-23 /pmc/articles/PMC8097728/ /pubmed/33997752 http://dx.doi.org/10.1016/j.sopen.2019.12.003 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Colonna, Alexander L.
Bellows, Brandon K.
Enniss, Toby M.
Young, Jason B.
McCrum, Marta
Nunez, Jade M.
Nirula, Raminder
Nelson, Richard E.
Reducing the pain: A cost-effectiveness analysis of transversus abdominis plane block using liposomal bupivacaine for outpatient laparoscopic ventral hernia repair
title Reducing the pain: A cost-effectiveness analysis of transversus abdominis plane block using liposomal bupivacaine for outpatient laparoscopic ventral hernia repair
title_full Reducing the pain: A cost-effectiveness analysis of transversus abdominis plane block using liposomal bupivacaine for outpatient laparoscopic ventral hernia repair
title_fullStr Reducing the pain: A cost-effectiveness analysis of transversus abdominis plane block using liposomal bupivacaine for outpatient laparoscopic ventral hernia repair
title_full_unstemmed Reducing the pain: A cost-effectiveness analysis of transversus abdominis plane block using liposomal bupivacaine for outpatient laparoscopic ventral hernia repair
title_short Reducing the pain: A cost-effectiveness analysis of transversus abdominis plane block using liposomal bupivacaine for outpatient laparoscopic ventral hernia repair
title_sort reducing the pain: a cost-effectiveness analysis of transversus abdominis plane block using liposomal bupivacaine for outpatient laparoscopic ventral hernia repair
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097728/
https://www.ncbi.nlm.nih.gov/pubmed/33997752
http://dx.doi.org/10.1016/j.sopen.2019.12.003
work_keys_str_mv AT colonnaalexanderl reducingthepainacosteffectivenessanalysisoftransversusabdominisplaneblockusingliposomalbupivacaineforoutpatientlaparoscopicventralherniarepair
AT bellowsbrandonk reducingthepainacosteffectivenessanalysisoftransversusabdominisplaneblockusingliposomalbupivacaineforoutpatientlaparoscopicventralherniarepair
AT ennisstobym reducingthepainacosteffectivenessanalysisoftransversusabdominisplaneblockusingliposomalbupivacaineforoutpatientlaparoscopicventralherniarepair
AT youngjasonb reducingthepainacosteffectivenessanalysisoftransversusabdominisplaneblockusingliposomalbupivacaineforoutpatientlaparoscopicventralherniarepair
AT mccrummarta reducingthepainacosteffectivenessanalysisoftransversusabdominisplaneblockusingliposomalbupivacaineforoutpatientlaparoscopicventralherniarepair
AT nunezjadem reducingthepainacosteffectivenessanalysisoftransversusabdominisplaneblockusingliposomalbupivacaineforoutpatientlaparoscopicventralherniarepair
AT nirularaminder reducingthepainacosteffectivenessanalysisoftransversusabdominisplaneblockusingliposomalbupivacaineforoutpatientlaparoscopicventralherniarepair
AT nelsonricharde reducingthepainacosteffectivenessanalysisoftransversusabdominisplaneblockusingliposomalbupivacaineforoutpatientlaparoscopicventralherniarepair